fingolimod hydrochloride has been researched along with Anti-Glomerular Basement Membrane Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, X; Liu, X; Ma, J; Mu, S; Sui, M; Wu, H; Xie, R; Zhou, J | 1 |
1 other study(ies) available for fingolimod hydrochloride and Anti-Glomerular Basement Membrane Disease
| Article | Year |
|---|---|
The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis.
Topics: Analysis of Variance; Animals; Anti-Glomerular Basement Membrane Disease; Apoptosis; CD4-Positive T-Lymphocytes; Creatinine; DNA Primers; Fingolimod Hydrochloride; Freund's Adjuvant; Gene Expression Regulation; Immune Sera; Immunoglobulin G; Immunosuppressive Agents; Interleukin-4; Male; Mice; Mice, Inbred C57BL; Prednisone; Propylene Glycols; Proteinuria; Rabbits; Real-Time Polymerase Chain Reaction; Receptors, Lysosphingolipid; Sphingosine; Spleen | 2012 |